Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "financial results" return 86 results.
Ceva posts strong double-digit growth again in H1 2015 >
Libourne 22 nd July 2015 - Consolidated sales of the Ceva Group reached €424m at the end of June 2015, representing growth of 16% and +12% at constant perimeter and exchange rates. Sales grew in all...
Ceva’s new generation Vectormune® AI vaccine proves to be a useful tool to control HPAI >
A paper* recently published in the peer-reviewed journal Vaccine** reports that Ceva’s new generation vaccine, Vectormune® AI, offers significant advantages over previously available vaccines against...
Ceva posts strong double-digit growth again in 2014 >
Consolidated sales of the Ceva Group reached €766m at the end of 2014, representing growth of 23% and +14.1% at a constant perimeter and exchange rates.
Tildren® receives FDA approval to control clinical signs of Navicular Syndrome >
Tildren® is now available in the US
Egypt study confirms that a single rHVT-H5 hatchery vaccination could be an effective tool to address A/H5N1 prevention >
Research confirms that in endemic countries the classical inactivated vaccines are less effective and hard to administer, while application of a rHVT vector hatchery vaccine is labour saving, cost eff...
Mérieux Développement becomes a shareholder of Ceva Santé Animale >
Ceva Santé Animale announces the arrival of a new shareholder, Mérieux Développement, the investment company of Institut Mérieux.
Ceva merges all R&D activity and nominates Dr. Steve Chu as member of the Executive Committee >
Libourne 4th September 2014 - Ceva Santé Animale announced the appointment of Dr.Chu to its executive committee with responsibility for all R&D activities. The move recognises the growing importan...
Mid-year results >
Ceva attracts strong investor support for 4th LMBO and returns to double-digit growth in first 6 months of 2014
New C.H.I.C.K. Program application for hatchery vaccination services >
Ceva boosts its hatchery vaccination services with powerful new C.H.I.C.K. Program app.
Cooperation between Veterinary Department of Myanmar and Ceva Santé Animale >
Towards a bilateral cooperation between the Livestock Breeding and Veterinary Department of Myanmar and Ceva Santé Animale